XML 26 R14.htm IDEA: XBRL DOCUMENT
v3.23.3

NET INCOME (LOSS) PER SHARE | 9 Months Ended
--- | ---
Sep. 30, 2023
Earnings Per Share [Abstract] |
NET INCOME (LOSS) PER SHARE | NET INCOME (LOSS) PER SHARE The Company follows the two-class method when computing net loss per common share when shares are issued that meet the definition of participating securities. The two-class method requires income available to common shareholders for the period to be allocated between common and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The two-class method also requires losses for the period to be allocated between common and participating securities based on their respective rights if the participating security contractually participates in losses. As holders of participating securities do not have a contractual obligation to fund losses, undistributed net losses are not allocated to nonvested restricted stock for purposes of the loss per share calculation. Presented in the table below is a reconciliation of the numerator and denominator for the basic earnings per share (“EPS”) calculations for the three and nine months ended September 30, 2023 and 2022 (in thousands):
| Three months ended September 30, |  | Nine months ended September 30,
| 2023 | 2022 |  | 2023 | 2022
Net income (loss) attributable to PureCycle Technologies | $ | 4,886 |  | $ | (34,948) |  |  | $ | (77,532) |  | $ | (75,384) |
Less income attributable to participating warrants | (480) |  | — |  |  | — |  | — |
Net income (loss) attributable to common shareholders | $ | 4,406 |  | $ | (34,948) |  |  | $ | (77,532) |  | $ | (75,384) |
Weighted average common shares outstanding, basic | 164,018 |  | 163,490 |  |  | 163,783 |  | 153,513 |
Net loss per share attributable to common stockholder, basic | $ | 0.03 |  | $ | (0.21) |  |  | $ | (0.47) |  | $ | (0.49) |
Presented in the table below is a reconciliation of the numerator and denominator for the diluted EPS calculations for the three and nine months ended September 30, 2023 and 2022 (in thousands):
| Three months ended September 30, |  | Nine months ended September 30,
| 2023 | 2022 |  | 2023 | 2022
Numerator: |  |  |  |  |
Net income (loss) attributable to PureCycle Technologies | $ | 4,886 |  | $ | (34,948) |  |  | $ | (77,532) |  | $ | (75,384) |
Less change in fair value of RTI Warrants | (4,049) |  | — |  |  | (1,485) |  | (553) |
Less income attributable to participating warrants | (81) |  | — |  |  | — |  | — |
Net income (loss) attributable to common shareholders | $ | 756 |  | $ | (34,948) |  |  | $ | (79,017) |  | $ | (75,937) |
Denominator: |  |  |  |  |
Weighted average common shares outstanding, basic | 164,018 |  | 163,490 |  |  | 163,783 |  | 153,513 |
Add common equivalent shares from warrants | 395 |  | — |  |  | 197 |  | 186 |
Add common equivalent shares from equity awards | 1,135 |  | — |  |  | — |  | — |
Weighted average common shares outstanding, diluted | 165,548 |  | 163,490 |  |  | 163,980 |  | 153,699 |
Net loss per share attributable to common stockholder, diluted | $ | 0.00 |  | $ | (0.21) |  |  | $ | (0.48) |  | $ | (0.49) |
Certain outstanding common share equivalents were excluded from the computation of diluted net income (loss) per share attributable to common stockholders for the periods presented as including them would have been anti-dilutive. For the three months ended September 30, 2023 and 2022, the Company had outstanding instruments of approximately 23.8 million and 24.7 million warrants, 0.6 million and 0.6 million stock options, 0.7 million and 2.6 million non-vested restricted stock units, 1.5 million and 1.1 million non-vested performance stock units, 4.0 million and 4.0 million contingently-issuable shares related to the Earnout, and 16.9 million and 0 shares issuable upon conversion of the Green Convertible Notes (as described further in Note 3 – Notes Payable and Debt Instruments) which could be dilutive to the calculation in the future, respectively. For the nine months ended September 30, 2023 and 2022, the Company had outstanding instruments of approximately 23.8 million and 23.8 million warrants, 1.1 million and 0.6 million stock options, 3.1 million and 2.6 million non-vested restricted stock units, 1.5 million and 1.1 million non-vested performance stock units, 4.0 million and 4.0 million contingently-issuable shares related to the Earnout, and 16.9 million and 0 shares issuable upon conversion of the Green Convertible Notes which could be dilutive to the calculation in the future, respectively.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration